Hypoxia-induced fibroblast growth factor 11 stimulates capillary-like endothelial tube formation. 2015

Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
Biomedical Research Institute and IRICT, Seoul National University Hospital, Seoul, Republic of Korea.

Low oxygen or hypoxia can be observed in the central region of solid tumors. Hypoxia is a strong stimulus for new blood vessel formation or angiogenesis, which is essential for tumor growth and progression. Fibroblast growth factor 11 (FGF11) is an intracellular non-secretory FGF whose function has not yet been fully characterized. In the present study, we demonstrated that FGF11 expression is upregulated under hypoxic conditions in human umbilical vein endothelial cells (HUVECs). FGF11 overexpression stimulated capillary-like tube formation, yet did not affect cell migration. Notably, FGF11 markedly increased the levels of tight junction proteins including occludin, zonula occludens-1 (ZO-1) and claudin-5 in HUVECs. The FGF11 promoter contains hypoxia response elements (HREs), and hypoxia-inducible factor-1 (HIF-1) binds to HREs to activate hypoxia-related genes. We demonstrated that hypoxia or HIF-1 expression under normoxic conditions increased the luciferase activity driven by the FGF11 promoter. However, deletion of the HREs from the FGF11 promoter rendered reporter gene activity unresponsive to hypoxia or HIF-1. Taken together, we propose that FGF11 may be involved in the stabilization of capillary-like tube structures associated with angiogenesis and may act as a modulator of hypoxia-induced pathological processes such as tumorigenesis.

UI MeSH Term Description Entries
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005346 Fibroblast Growth Factors A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family. DNA Synthesis Factor,Fibroblast Growth Factor,Fibroblast Growth Regulatory Factor,Growth Factor, Fibroblast,Growth Factors, Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D051795 Hypoxia-Inducible Factor 1, alpha Subunit Hypoxia-inducible factor 1, alpha subunit is a basic helix-loop-helix transcription factor that is regulated by OXYGEN availability and is targeted for degradation by VHL TUMOR SUPPRESSOR PROTEIN. Hypoxia Inducible Factor 1, alpha Subunit
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
April 2017, Calcified tissue international,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
January 1991, EXS,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
December 2009, PloS one,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
January 2001, In vitro cellular & developmental biology. Animal,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
January 2019, Biochemical and biophysical research communications,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
November 2015, Endocrinology,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
May 1999, Microvascular research,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
November 2002, The Journal of laboratory and clinical medicine,
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
January 2018, Methods in molecular biology (Clifton, N.J.),
Jimin Yang, and Woo Jean Kim, and Hyoung Oh Jun, and Eun Ju Lee, and Kyeong Won Lee, and Jae-Yeon Jeong, and Sae-Won Lee
January 2006, Endothelium : journal of endothelial cell research,
Copied contents to your clipboard!